Sanofi-aventis announced the positive results of the first, placebo-controlled study of the GetGoal Phase III clinical trial program with lixisenatide, a novel, once daily GLP-1 agonist, for the treatment of Type-2 diabetes (T2DM)….

Obesity is a risk factor for the progression of chronic kidney disease (CKD). This study aimed to determine the effect of intentional weight loss on proteinuria and kidney function….

This study evualuated the 2-year safety and efficacy of adding sitagliptin or glipizide to ongoing metformin in patients with Type 2 diabetes….

Scientists recently presented preliminary research findings that identify a specific gene as a potential new target for treating obesity-related diseases….

Two years ago, a Baylor University researcher developed an effective and accurate electromagnetic sensor that provides patients with diabetes a noninvasive alternative to reading their blood glucose levels. There was just one problem: it was too big to carry around. That’s all changed….

Women who eat a high-carbohydrate diet — especially a lot of bread, pizza, jam, and similar products — are at an increased risk of coronary heart disease, researchers said….

Consuming a higher amount of added sugars in processed or prepared foods is associated with lower levels of high-density lipoprotein cholesterol (HDL-C, the “good cholesterol”) and higher levels of triglycerides, which are important risk factors for cardiovascular disease, according to a study.…

Advances in the genetics of Type 2 diabetes have provided a foundation for individual treatment strategies, which should be a continuing goal of research, according to a consensus statement from diabetes specialists….

Researchers and clinicians from across the UK have been part of a pan-European team that has developed the first Europe-wide strategy for the prevention of Type 2 diabetes. The project received substantial funding of 1.2 million euros from the European Union (EU).…

Effect of the Look AHEAD Study Intervention on medication use and related cost to treat cardiovascular disease risk factors in individuals with Type 2 diabetes….